Tempest Therapeutics TPST
NASDAQ TPST
$0.52 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Notes Payables (2022)

Updated

Tempest Therapeutics (TPST) reported Notes Payables of $3.5 million for Q3 2022, up 75.0% from the prior quarter.

Analysis

Tempest Therapeutics (TPST) Notes Payables (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Tempest Therapeutics 8.31 Mn -22.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 3.50 Mn
Jun 30, 2022 2.00 Mn
API Access

Tempest Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=TPST&period=max&api_key=YOUR_API_KEY